Displacement of spin-labeled drugs from drug-specific antibodies in human serum can be measured by use of electron spin resonance. This "spin immunoassay" has advantages of speed, simplicity, and small volume requirements over other standard techniques such as gas-liquid, liquid-liquid, or thin-layer chromatography. Unlike radioimmunoassay, there is no need to separate free and bound label and there are no radiation hazards. We present clinical and experimental data showing how this method can be applied to the routine determination of morphine and diphenylhydantoin concentrations in serum.
#{149} inter-method comparison #{149} toxicology
The (3) . In this method 5-(4'-methylphenyl)-5-phenylhydantoin was added to the serum (1 ml) as an internal standard, to give a final concentration of 50 sg/ml. This was followed by the addition of 1 ml of potassium phosphate buffer (0.25 mol/liter, pH 7.4). The drug was extracted into 6 ml of ethylene dichloride, 5 ml of hexane was added, and the organic phase was extracted with 4.5 ml of K3P04 (0.2 mol/liter).
The 3.5-ml aqueous phase was acidified with 0.3 ml of HC1 (5 mol/liter) and finally ex- signal is subtracted from the ESR response observed for a serum sample containing the drug, there is an increase in total sensitivity as compared to urine (Figure 3) . A total peak-to-peak difference of 10 units (one ESR chart unit equals 2 mm) is taken as the lower limit of detection.
When 5O-tl capillary tubes are used, the sensitivity of the assay is increased in serum by about 10-fold as compared to urine ( Figure  4) . A further increase in sensitivity was obtained by using a quartz aqueous solution cell (Figure 4 ). With this cell there is a total sample volume in the spectrometer cavity of 300 tl as compared to the 5O-il volume for the capillary tubes. This increased sensitivity results from the fact that the ESR spectrome- for morphine and also gas-liquid chromatography for diphenylhydantoin. In the case of morphine the distribution phase was complete in 90 mm, after which the disappearance was linear up to 6 h ( Figure 6 ). Not only was there good agreement between the half-lives obtained by both methods for this fast phase of disappearance (t312 (14C) = 1.9 h, t1,,2 (ESR) = 1.6 h), but also there was excellent agreement between the concentrations at each sample point. The sample drawn at 24 h represented the second, slow phase of morphine disap- ter detects the total number of free electrons in the microwave cavity rather than their concentration (7). Thus, the same number of spin-labeled morphine molecules that were detected in the 50-zl sample, when now placed in the large volume cell, gives a sixfold decrease in the minimal detectable morphine concentration to 35 nmol/liter. This limit of assay sensitivity agrees quite well with the instrumental limit of detection of nitroxide-labeled drug, 20 nmol/ liter (1).
In a subsequent series of studies we examined the application of this technique to the determination of diphenylhydantoin.
The assay sensitivity required for the routine clinical monitoring of diphenylhydantom in serum can be achieved simply with the 50-id sample volume and a relatively low microwave power of 12 mW ( Figure  5 ). The relatively high degree of serum binding of diphenylhydantoin results in a virtual disappearance of the background resonance signal in this assay. Thus, as was the case for morphine, the sensitivity of the diphenylhydantoin assay can quickly and conveniently be increased by about 100-fold by increasing the sample volume and microwave power. in serum to that for the same concentration of spin-labeled drug in water. The data (Table 1) 
